MedTrace Logo

Left Lateral Position Versus Supine Position in Colonoscopy

NCT06664762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2026-04-29

Study results available
· View outcomes & findings →

Summary

Currently, colonoscopy is a minimally invasive method that can be used as a diagnostic and therapeutic method by endoscopists, gastroenterologists and coloproctologists. Due to the importance and big impact this method has, it is necessary to both optimize its efficiency, and improve its quality, which is one of the main objectives of this protocol.

By observing which position its faster and which one also results in fewer complications when performing a colonoscopy without reducing its performance and following all the internationally established quality standards regarding colonoscoscopy.

The risk of this protocol implies a risk no greater than the minumum the procedure itself has, and does not generate extra cost for all of the patients subjected to this protocol.

Conditions

  • Colorectal Cancer Screening

Interventions

BEHAVIORAL

Left lateral position intervention

Patients will be randomized and asigned to start and remain in left lateral position during the colonoscopy

BEHAVIORAL

Supine position intervention

Patients will be randomized and asigned to start and remain in supine position during the colonoscopy

Sponsors & Collaborators

  • Hospital Civil Juan I. Menchaca

    collaborator OTHER

  • Instituto Mexicano del Seguro Social

    collaborator OTHER_GOV

  • Hospital Civil de Guadalajara

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-27
Primary Completion
2025-07-30
Completion
2025-08-06

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06664762 on ClinicalTrials.gov